Bio-Rad Reports Third-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Bio-Rad Labs (BIO) Misses Q3 EPS by 24c
November 1, 2018 4:39 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.91, $0.24 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $545.1 million versus the consensus estimate of $538.68 million.
2018 Financial Outlook
For the full year 2018, the company is reiterating the previous currency-neutral growth... More



